Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
E.T. Molenaar, A.E. Voskuyl, H.J. Dinant, P.D. Bezemer, M. Boers, B.A. Dijkmans.
Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission.
Arthritis Rheumatism, 50 (2004), pp. 36-42
[2.]
T. Mottonen, P. Hannonen, M. Korpela, M. Nissilae, H. Kautiainen, J. Ilonen, et al.
Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.
Arthritis Rheumatism, 46 (2002), pp. 894-898
[3.]
K. Puolakka, H. Kautiainen, T. Mottonen, P. Hannonen, M. Korpela, M. Hakala, FIN-RACo Trial Group, et al.
Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
Arthritis Rheumatism, 52 (2005), pp. 36-41
[4.]
C. Grigor, H. Capell, A. Stirling, A.D. McMahon, P. Lock, R. Vallance, et al.
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial.
Lancet, 364 (2004), pp. 263-269
[5.]
E.W. Saint Clair, D.M. Van der Heijde, J.S. Smolen, R.N. Maini, J.M. Bathon, P. Emery, et al.
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.
Arthritis Rheumatism, 50 (2004), pp. 3432-3443
[6.]
P.C. Taylor, A. Steuer, J. Gruber, D.O. Cosgrove, M.J. Blomley, P.A. Marsters, et al.
Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis.
Arthritis Rheumatism, 50 (2004), pp. 1107-1116
[7.]
P.C. Taylor, A. Steuer, J. Gruber, C. McClinton, D.O. Cosgrove, M.J. Blomley, et al.
Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis.
Arthritis Rheumatism, 54 (2006), pp. 47-53
[8.]
M.A. Quinn, P.G. Conaghan, P.J. O’ Connor, Z. Karim, A. Greenstein, A. Brown, et al.
Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized double-blind, placebo-controlled trial.
Arthritis Rheumatism, 52 (2005), pp. 27-35
[9.]
Y.P. Goekoop-Ruiterman, J.K. De Vries-Bouwstra, C.F. Allaart, D. Van Zeben, P.J. Kerstens, J.M. Hazes, et al.
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.
Arthritis Rheumatism, 52 (2005), pp. 3381-3390
Copyright © 2006. Elsevier España S.L. Barcelona
